Improving precision medicine: how the Oncotype DX test can help shape treatment strategies
Antonio Carlos Buzaid (BRA)
• 12-year update on the TAILORx Study
• How Anti-Müllerian hormone (AMH) can guide therapeutical decision-making in pre-menopausal patients, with positive lymph node
• Subanalysis of the TAILORx Study: correlation between recurrence score and anthracycline use
